Medicine

Researchers and policymakers must challenge the default framing and stereotypical minority myth mindset which uniformly classifies AANHPI communities as low-risk, hindering both visibility and resource allocation.  The post Overlooked in the Overdose Crisis: Addressing Substance Use Treatment for Asian American, Native Hawaiian, and Pacific Islander Communities appeared first on MedCity News.

In partnership with Cost Plus Drugs and Waltz Health, Serve You Rx has added Stelara biosimilars Otulfi and Yesintek to its formulary. The post Serve You Rx Adds 2 Stelara Biosimilars to Formulary to Help Patients Save Costs appeared first on MedCity News.

When an attack or other issue occurs, the main difference between being down for months versus minutes or a day is having a mature and tested incident response plan. Without a plan, your cybersecurity team is flying blind, resulting in confusion and inefficiency that significantly slows your response time. The post How Healthcare Can Reduce…

The case for modernization isn’t solely about improving efficiency. It’s about equipping hospitals with the resources necessary to manage risk proactively, respond to negative trends quickly, and prioritize patient safety with high reliability.   The post The Hidden Cost of Disconnected Quality Systems: Why Hospitals Should Modernize Now appeared first on MedCity News.

Hospitals saw improved financial performance during the first four months of the year, with operating margins rising to 3.3% thanks to higher patient volumes and more efficient throughput. However, experts warn that hospitals remain financially vulnerable as non-labor expenses continue to rise. The post Hospitals See Financial Gains Due to Higher Volumes & Improved Throughput…

Amazon Pharmacy recently launched a new caregiver feature and expanded PillPack to Medicare Part D. The company says the updates will support medication adherence. The post Amazon Pharmacy Brings PillPack to Medicare and Adds Caregiver Feature — Will It Make a Difference? appeared first on MedCity News.

Johnson & Johnson has projected its lung cancer drug Rybrevant could achieve $5 billion in peak revenue. At the recent ASCO annual meeting, J&J executive Joshua Bauml explained his company’s strategy for this drug in lung cancer and beyond. The post J&J’s Growth Strategy in Lung Cancer Borrows From Its Experience in Multiple Myeloma appeared…

Pear Suite recently won the payer/provider technology track of MedCity News’ INVEST Pitch Perfect contest. The startup provides a software platform for community health workers that helps them share data, submit claims and maintain compliance. The post INVEST Pitch Perfect Spotlight: How Pear Suite Makes Sure Community Health Workers Get Paid appeared first on MedCity…

UH Group replaces its CEO, the payer’s alleged nursing home practices, the future of pharmacy benefit managers, and the healthcare implications of the budget bill are part of the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch. The post Debunked Episode 16:…

Behavioral health doesn’t need tech that replaces people. It needs technology that respects them, amplifying what clinicians do best and helping more people get the care they deserve. The post The Behavioral Health AI Boom Is Real. So Are the Risks appeared first on MedCity News.